Publication Information

{'id': 'https://openalex.org/W4322760569', 'doi': 'https://doi.org/10.1158/1538-7445.sabcs22-p2-01-06', 'title': 'Abstract P2-01-06: Real-world outcome and cost analysis of the addition of pertuzumab to neoadjuvant therapy in localized HER2 positive breast cancer: a single center experience', 'display_name': 'Abstract P2-01-06: Real-world outcome and cost analysis of the addition of pertuzumab to neoadjuvant therapy in localized HER2 positive breast cancer: a single center experience', 'publication_year': 2023, 'publication_date': '2023-03-01', 'ids': {'openalex': 'https://openalex.org/W4322760569', 'doi': 'https://doi.org/10.1158/1538-7445.sabcs22-p2-01-06'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.sabcs22-p2-01-06', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5067293852', 'display_name': 'François Panet', 'orcid': 'https://orcid.org/0000-0002-4949-2144'}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Francois Panet', 'raw_affiliation_strings': ['1Department of oncology, McGill University, Mont-Royal, Quebec, Canada'], 'affiliations': [{'raw_affiliation_string': '1Department of oncology, McGill University, Mont-Royal, Quebec, Canada', 'institution_ids': ['https://openalex.org/I5023651']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113922773', 'display_name': 'Matt Young', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Matt Young', 'raw_affiliation_strings': ['2Department of oncology, McGill University'], 'affiliations': [{'raw_affiliation_string': '2Department of oncology, McGill University', 'institution_ids': ['https://openalex.org/I5023651']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5012678671', 'display_name': 'Stephanie M. Wong', 'orcid': 'https://orcid.org/0000-0002-6850-2192'}, 'institutions': [{'id': 'https://openalex.org/I2801824472', 'display_name': 'Jewish General Hospital', 'ror': 'https://ror.org/056jjra10', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801824472']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Stephanie Wong', 'raw_affiliation_strings': ['3Segal cancer centre, Jewish General Hospital, Lady Davis institute'], 'affiliations': [{'raw_affiliation_string': '3Segal cancer centre, Jewish General Hospital, Lady Davis institute', 'institution_ids': ['https://openalex.org/I2801824472']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5089537082', 'display_name': 'Alice Dragomir', 'orcid': 'https://orcid.org/0000-0003-3858-3777'}, 'institutions': [{'id': 'https://openalex.org/I5023651', 'display_name': 'McGill University', 'ror': 'https://ror.org/01pxwe438', 'country_code': 'CA', 'type': 'education', 'lineage': ['https://openalex.org/I5023651']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Alice Dragomir', 'raw_affiliation_strings': ['4Faculty of Medicine, Department of Urology, McGill University'], 'affiliations': [{'raw_affiliation_string': '4Faculty of Medicine, Department of Urology, McGill University', 'institution_ids': ['https://openalex.org/I5023651']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058076973', 'display_name': 'April A. N. Rose', 'orcid': 'https://orcid.org/0000-0002-9845-4603'}, 'institutions': [{'id': 'https://openalex.org/I2801824472', 'display_name': 'Jewish General Hospital', 'ror': 'https://ror.org/056jjra10', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801824472']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'April A. N. Rose', 'raw_affiliation_strings': ['5Segal cancer centre, Jewish General Hospital, Lady Davis institute'], 'affiliations': [{'raw_affiliation_string': '5Segal cancer centre, Jewish General Hospital, Lady Davis institute', 'institution_ids': ['https://openalex.org/I2801824472']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5049481562', 'display_name': 'Lawrence Panasci', 'orcid': 'https://orcid.org/0000-0002-5141-5594'}, 'institutions': [{'id': 'https://openalex.org/I2801824472', 'display_name': 'Jewish General Hospital', 'ror': 'https://ror.org/056jjra10', 'country_code': 'CA', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801824472']}], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Lawrence Panasci', 'raw_affiliation_strings': ['6Segal cancer centre, Jewish General Hospital, Lady Davis institute.'], 'affiliations': [{'raw_affiliation_string': '6Segal cancer centre, Jewish General Hospital, Lady Davis institute.', 'institution_ids': ['https://openalex.org/I2801824472']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.779, 'has_fulltext': False, 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.63932, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 78, 'max': 84}, 'biblio': {'volume': '83', 'issue': '5_Supplement', 'first_page': 'P2', 'last_page': '06'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9885, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9885, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10183', 'display_name': 'Breast Cancer Treatment Studies', 'score': 0.9855, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12829', 'display_name': 'Advanced Breast Cancer Therapies', 'score': 0.9635, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/pertuzumab', 'display_name': 'Pertuzumab', 'score': 0.97884524}, {'id': 'https://openalex.org/keywords/neoadjuvant-therapy', 'display_name': 'Neoadjuvant Therapy', 'score': 0.70826674}, {'id': 'https://openalex.org/keywords/clinical-endpoint', 'display_name': 'Clinical endpoint', 'score': 0.54316574}], 'concepts': [{'id': 'https://openalex.org/C2781164504', 'wikidata': 'https://www.wikidata.org/wiki/Q1998021', 'display_name': 'Pertuzumab', 'level': 5, 'score': 0.97884524}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8840791}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.7154222}, {'id': 'https://openalex.org/C2778292576', 'wikidata': 'https://www.wikidata.org/wiki/Q6991934', 'display_name': 'Neoadjuvant therapy', 'level': 4, 'score': 0.70826674}, {'id': 'https://openalex.org/C2779786085', 'wikidata': 'https://www.wikidata.org/wiki/Q412616', 'display_name': 'Trastuzumab', 'level': 4, 'score': 0.6794708}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.6512656}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.58887595}, {'id': 'https://openalex.org/C203092338', 'wikidata': 'https://www.wikidata.org/wiki/Q1340863', 'display_name': 'Clinical endpoint', 'level': 3, 'score': 0.54316574}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.5023947}, {'id': 'https://openalex.org/C31174226', 'wikidata': 'https://www.wikidata.org/wiki/Q64855140', 'display_name': 'Perioperative', 'level': 2, 'score': 0.45971727}, {'id': 'https://openalex.org/C191093355', 'wikidata': 'https://www.wikidata.org/wiki/Q9250577', 'display_name': 'Exact test', 'level': 2, 'score': 0.42859468}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.3476976}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.29573816}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.sabcs22-p2-01-06', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.74, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4237763823', 'https://openalex.org/W4210586974', 'https://openalex.org/W3139229505', 'https://openalex.org/W3137246495', 'https://openalex.org/W3001641205', 'https://openalex.org/W2914195240', 'https://openalex.org/W2891579961', 'https://openalex.org/W2769397950', 'https://openalex.org/W2330582602', 'https://openalex.org/W2019769353'], 'abstract_inverted_index': {'Abstract': [0], 'BACKGROUND:': [1], 'Breast': [2, 533], 'cancer': [3, 8], 'is': [4, 35, 59, 176, 405, 422, 439], 'the': [5, 17, 25, 70, 84, 125, 140, 144, 177, 190, 197, 275, 306, 312, 328, 346, 365, 373, 394, 412, 426, 508, 529], 'most': [6], 'common': [7], 'in': [9, 83, 92, 139, 196, 222, 290, 303, 305, 322, 364, 372, 434, 451, 464, 515], 'woman': [10], 'and': [11, 42, 78, 122, 150, 188, 200, 256, 293, 368, 390, 447, 463, 477, 504], 'can': [12], 'be': [13, 352], 'classified': [14], 'based': [15], 'on': [16, 120, 124, 204, 407], 'expression': [18], 'of': [19, 72, 134, 179, 192, 269, 314, 330, 348, 360, 414, 431, 449, 507, 510, 528], 'hormonal': [20], 'receptor': [21, 30], 'as': [22, 24], 'well': [23, 388], 'human': [26], 'epidermal': [27], 'growth': [28], 'factor': [29], '2': [31], '(HER2).': [32], 'HER2': [33, 74, 244, 263, 456, 517], 'amplification': [34], 'associated': [36, 272, 391], 'with': [37, 76, 81, 168, 214, 261, 273, 311, 325, 339, 354, 384, 392, 458, 469], 'an': [38], 'aggressive': [39], 'clinical': [40], 'course': [41], 'higher': [43], 'recurrence': [44], 'rates': [45], 'following': [46], 'curative': [47], 'intend': [48], 'surgery.': [49, 182], 'For': [50], 'non-metastatic': [51], 'T2': [52], 'or': [53, 169], 'node-positive': [54], 'HER2-positive': [55], 'disease': [56, 341], 'neoadjuvant': [57, 85, 141, 160, 241, 349, 382, 432, 459, 513], 'treatment': [58], 'favored.': [60], 'The': [61, 267, 284, 320], 'National': [62], 'Comprehensive': [63], 'Cancer': [64, 534, 545], 'Network': [65], '(NCCN)': [66], 'guidelines': [67], 'have': [68], 'endorsed': [69], 'use': [71, 313], 'dual': [73, 262, 385, 455], 'blockage': [75], 'trastuzumab': [77, 252, 374, 401, 467], 'pertuzumab': [79, 88, 154, 270, 315, 326, 350, 511], 'combined': [80], 'chemotherapy': [82, 242, 383, 462, 470], 'setting.': [86], 'However,': [87], 'isn’t': [89], 'frequently': [90], 'reimbursed': [91], 'public': [93], 'health': [94], 'care': [95], 'systems': [96], 'for': [97, 113, 243, 308, 333, 417], 'this': [98], 'indication.': [99], 'Patients': [100], 'who': [101, 239, 453], 'don’t': [102], 'achieve': [103], 'a': [104, 131, 223, 299, 355, 521], 'pathological': [105], 'complete': [106, 444], 'response': [107, 445], '(pCR)': [108, 446], 'at': [109, 143, 181, 471], 'surgery': [110, 450], 'are': [111, 185], 'eligible': [112, 332, 416], 'adjuvant': [114, 334, 344, 418, 437], 'T-DM1,': [115, 345], 'adding': [116], 'significant': [117, 301, 485], 'side': [118, 201], 'effects': [119], 'patients': [121, 135, 166, 249, 258, 331, 338, 415, 452, 465], 'cost': [123, 191, 227, 347, 359, 409, 505], 'healthcare': [126], 'system.': [127], 'METHODS:': [128], 'We': [129, 235, 296], 'conducted': [130], 'retrospective': [132], 'analysis': [133, 379, 506], 'receiving': [136, 466], 'anti-HER2': [137, 193, 254, 357], 'therapy': [138, 161, 195, 255, 514], 'setting': [142, 199], 'Jewish': [145, 472], 'General': [146, 473], 'hospital': [147], 'between': [148, 475], '2015': [149, 476], '2021.': [151, 478], 'After': [152], '2019,': [153], 'was': [155, 228, 271, 288, 387], 'routinely': [156], 'added': [157], 'to': [158, 164, 186, 398, 424, 512], 'standard': [159], 'enabling': [162], 'us': [163], 'compare': [165, 189], 'treated': [167, 260], 'without': [170], 'dual-HER2': [171], 'blockade.': [172], 'Our': [173, 377], 'primary': [174], 'endpoint': [175], 'percentage': [178], 'pCR': [180, 276, 286, 323, 395], 'Secondary': [183], 'objectives': [184], 'estimate': [187, 425], 'targeted': [194], 'perioperative': [198], 'effect': [202], 'burden': [203], 'patients.': [205], 'Statistical': [206], 'analyses': [207], 'were': [208, 259], 'done': [209], 'using': [210, 230], 'fisher': [211], 'exact': [212], 'test': [213], 'statistical': [215], 'significance': [216], 'defined': [217], 'p': [218, 281, 480], 'value': [219], '<': [220, 481], '0.05': [221], 'one-sided': [224], 'test.': [225], 'Drug': [226], 'calculated': [229], 'publicly': [231], 'available': [232], 'resources.': [233], 'RESULTS:': [234], 'identified': [236], '83': [237], 'patient': [238], 'underwent': [240], 'amplified': [245], 'breast': [246, 519], 'cancer.': [247], '44': [248], 'received': [250, 343, 454], 'only': [251, 468], 'has': [253], '39': [257], 'blockade': [264, 457], 'containing': [265, 400], 'pertuzumab.': [266], 'addition': [268, 509], 'improved': [274], 'rate': [277, 287, 324, 396], '(67%': [278], 'vs.': [279, 317], '27%;': [280], '=': [282], '0.0016).': [283], 'increased': [285, 321, 393], 'observed': [289], 'hormone-receptor': [291], 'positive': [292, 518], 'negative': [294], 'tumors.': [295], 'also': [297], 'described': [298], 'non-statistically': [300, 484], 'trend': [302], 'reduction': [304], 'requirement': [307], 'axillary': [309], 'dissection': [310], '(28%': [316], '39%;': [318], 'P=0.2208).': [319], 'reduced': [327], 'number': [329], 'T-DM1.': [335, 419], 'If': [336], 'all': [337], 'residual': [340], 'had': [342], 'would': [351], 'neutral,': [353], 'mean': [356], 'drug': [358, 408], '65': [361], '150': [362], 'CA$': [363, 371], 'pertuzumab-trastuzumab': [366, 433, 460], 'group': [367], '66': [369], '116': [370], 'group.': [375], 'CONCLUSION:': [376], 'real-world': [378], 'confirmed': [380], 'that': [381], 'HER2-blockade': [386], 'tolerated': [389], 'compared': [397], 'regimens': [399], 'only.': [402], 'This': [403], 'measure': [404], 'neutral': [406], 'by': [410], 'reducing': [411], 'amount': [413], 'Further': [420], 'research': [421], 'warranted': [423], 'overall': [427], 'health-care': [428], 'utilization': [429], 'costs': [430], 'settings': [435], 'where': [436], 'T-DM1': [438], 'available.': [440], 'Table': [441], '3:': [442], 'Pathologic': [443], 'type': [448], 'plus': [461], 'Hospital': [474], '**': [479], '0,01,': [482], 'ns': [483], 'Citation': [486], 'Format:': [487], 'Francois': [488], 'Panet,': [489], 'Matt': [490], 'Young,': [491], 'Stephanie': [492], 'Wong,': [493], 'Alice': [494], 'Dragomir,': [495], 'April': [496], 'A.': [497], 'N.': [498], 'Rose,': [499], 'Lawrence': [500], 'Panasci.': [501], 'Real-world': [502], 'outcome': [503], 'localized': [516], 'cancer:': [520], 'single': [522], 'center': [523], 'experience': [524], '[abstract].': [525], 'In:': [526], 'Proceedings': [527], '2022': [530, 536], 'San': [531, 539], 'Antonio': [532], 'Symposium;': [535], 'Dec': [537], '6-10;': [538], 'Antonio,': [540], 'TX.': [541], 'Philadelphia': [542], '(PA):': [543], 'AACR;': [544], 'Res': [546], '2023;83(5': [547], 'Suppl):Abstract': [548], 'nr': [549], 'P2-01-06.': [550]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4322760569', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}], 'updated_date': '2025-01-08T04:57:18.293848', 'created_date': '2023-03-03'}